AR022646A1 - MOLÉCULA POLINUCLEOTíDICA QUE COMPRENDE UNA SECUENCIA DE STREPTOMYCES AVERMITILES QUE DIRIGE LA RELACIoN DE AVERMICTINAS B2: B1, VECTOR RECOMBINANTE, CÉLULA HUÉSPED, PROCEDIMIENTO PARA OBTENER NUEVA CEPA DE S.AVERMITILIS, CÉLULA DE S.AVERMITILES Y COMPOSICIoN DE CICLOHEXIL B2: CICLOHEXIL B1 AVERMECT - Google Patents
MOLÉCULA POLINUCLEOTíDICA QUE COMPRENDE UNA SECUENCIA DE STREPTOMYCES AVERMITILES QUE DIRIGE LA RELACIoN DE AVERMICTINAS B2: B1, VECTOR RECOMBINANTE, CÉLULA HUÉSPED, PROCEDIMIENTO PARA OBTENER NUEVA CEPA DE S.AVERMITILIS, CÉLULA DE S.AVERMITILES Y COMPOSICIoN DE CICLOHEXIL B2: CICLOHEXIL B1 AVERMECTInfo
- Publication number
- AR022646A1 AR022646A1 ARP000104131A ARP000104131A AR022646A1 AR 022646 A1 AR022646 A1 AR 022646A1 AR P000104131 A ARP000104131 A AR P000104131A AR P000104131 A ARP000104131 A AR P000104131A AR 022646 A1 AR022646 A1 AR 022646A1
- Authority
- AR
- Argentina
- Prior art keywords
- polinucleotydic
- hydroverse
- cecetia
- avermycines
- avermitible
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
- C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14864599P | 1999-08-12 | 1999-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR022646A1 true AR022646A1 (es) | 2002-09-04 |
Family
ID=22526696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000104131A AR022646A1 (es) | 1999-08-12 | 2000-08-10 | MOLÉCULA POLINUCLEOTíDICA QUE COMPRENDE UNA SECUENCIA DE STREPTOMYCES AVERMITILES QUE DIRIGE LA RELACIoN DE AVERMICTINAS B2: B1, VECTOR RECOMBINANTE, CÉLULA HUÉSPED, PROCEDIMIENTO PARA OBTENER NUEVA CEPA DE S.AVERMITILIS, CÉLULA DE S.AVERMITILES Y COMPOSICIoN DE CICLOHEXIL B2: CICLOHEXIL B1 AVERMECT |
Country Status (39)
| Country | Link |
|---|---|
| US (3) | US6632673B1 (es) |
| EP (1) | EP1200606B1 (es) |
| JP (1) | JP3884651B2 (es) |
| KR (1) | KR100489856B1 (es) |
| CN (1) | CN1186446C (es) |
| AP (1) | AP2002002418A0 (es) |
| AR (1) | AR022646A1 (es) |
| AT (1) | ATE341632T1 (es) |
| AU (1) | AU778837B2 (es) |
| BG (1) | BG65902B1 (es) |
| BR (1) | BRPI0013119B8 (es) |
| CA (1) | CA2380872C (es) |
| CO (1) | CO5290295A1 (es) |
| CY (1) | CY1105778T1 (es) |
| CZ (1) | CZ304402B6 (es) |
| DE (1) | DE60031126T2 (es) |
| DK (1) | DK1200606T3 (es) |
| EA (1) | EA200200056A1 (es) |
| ES (1) | ES2272299T3 (es) |
| GT (1) | GT200000136A (es) |
| HK (1) | HK1046710B (es) |
| HR (1) | HRP20020130A2 (es) |
| HU (1) | HU230600B1 (es) |
| IL (2) | IL147563A0 (es) |
| IS (1) | IS6250A (es) |
| MA (1) | MA26813A1 (es) |
| MX (1) | MXPA02001513A (es) |
| NO (1) | NO20020664L (es) |
| NZ (1) | NZ516517A (es) |
| OA (1) | OA11998A (es) |
| PA (1) | PA8499501A1 (es) |
| PE (1) | PE20010690A1 (es) |
| PL (1) | PL203818B1 (es) |
| PT (1) | PT1200606E (es) |
| SK (1) | SK288086B6 (es) |
| TN (1) | TNSN00171A1 (es) |
| UY (1) | UY26286A1 (es) |
| WO (1) | WO2001012821A1 (es) |
| ZA (1) | ZA200201072B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001012821A1 (en) * | 1999-08-12 | 2001-02-22 | Pfizer Products Inc. | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| JP2005517406A (ja) * | 2002-02-12 | 2005-06-16 | ファイザー・プロダクツ・インク | Ｂ２：Ｂ１アベルメクチン比を支配するＳｔｒｅｐｔｏｍｙｃｅｓａｖｅｒｍｉｔｉｌｉｓ遺伝子 |
| US7943160B2 (en) * | 2002-05-09 | 2011-05-17 | Scimetrics Limited Corp. | Pest control methods |
| US9493744B2 (en) * | 2012-06-20 | 2016-11-15 | Genentech, Inc. | Methods for viral inactivation and other adventitious agents |
| KR102657859B1 (ko) | 2021-04-07 | 2024-04-16 | 윤재식 | 일체형 내화 소켓 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5525506A (en) | 1987-01-23 | 1996-06-11 | Pfizer Inc. | Process for production of avermectins and cultures therefor |
| IN167980B (es) * | 1987-01-23 | 1991-01-19 | Pfizer | |
| US5234831A (en) | 1987-01-23 | 1993-08-10 | Pfizer Inc | Cultures for production of B avermectins |
| US5238848A (en) | 1987-01-23 | 1993-08-24 | Pfizer Inc | Cultures for production of avermectins |
| EP0313297B1 (en) | 1987-10-23 | 1993-05-19 | Pfizer Inc. | Process for production of avermectin aglycones and cultures therefor |
| US5240850A (en) | 1987-10-23 | 1993-08-31 | Pfizer Inc. | Cultures for production of avermectin aglycones |
| NZ233116A (en) | 1989-03-31 | 1994-09-27 | Merck & Co Inc | Cloning genes from steptomyces avermitilis for avermectin biosynthesis |
| US5252474A (en) | 1989-03-31 | 1993-10-12 | Merck & Co., Inc. | Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use |
| CA2167520C (en) | 1993-07-30 | 1999-07-27 | Claudio D. Denoya | Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| FI942725A (fi) | 1993-12-16 | 1995-06-17 | Pfizer | Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US6096548A (en) | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
| JP2001504325A (ja) | 1996-09-27 | 2001-04-03 | マキシジェン，インコーポレイテッド | 回帰的配列シャフリングおよび選択による遺伝子治療の最適化のための方法 |
| EP2261373A3 (en) | 1997-01-17 | 2011-12-14 | Codexis Mayflower Holdings, LLC | Evolution of whole cells and organisms by recursive sequence recombination |
| AU1449499A (en) | 1997-10-31 | 1999-05-24 | Maxygen, Incorporated | Modification of virus tropism and host range by viral genome shuffling |
| CN1521180A (zh) * | 1998-02-13 | 2004-08-18 | �Ʒ� | 介导除虫菌素b2：b1比例的除虫链霉菌基因 |
| US6248579B1 (en) * | 1998-02-13 | 2001-06-19 | Pfizer Inc | Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| WO2001012821A1 (en) * | 1999-08-12 | 2001-02-22 | Pfizer Products Inc. | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
-
2000
- 2000-07-24 WO PCT/IB2000/001017 patent/WO2001012821A1/en active Application Filing
- 2000-07-24 AU AU58386/00A patent/AU778837B2/en not_active Expired
- 2000-07-24 DK DK00944154T patent/DK1200606T3/da active
- 2000-07-24 HU HU0202487A patent/HU230600B1/hu unknown
- 2000-07-24 EA EA200200056A patent/EA200200056A1/ru unknown
- 2000-07-24 CZ CZ2002-296A patent/CZ304402B6/cs not_active IP Right Cessation
- 2000-07-24 ES ES00944154T patent/ES2272299T3/es not_active Expired - Lifetime
- 2000-07-24 EP EP00944154A patent/EP1200606B1/en not_active Expired - Lifetime
- 2000-07-24 NZ NZ516517A patent/NZ516517A/en unknown
- 2000-07-24 KR KR10-2002-7001807A patent/KR100489856B1/ko active IP Right Grant
- 2000-07-24 MX MXPA02001513A patent/MXPA02001513A/es active IP Right Grant
- 2000-07-24 OA OA1200200025A patent/OA11998A/en unknown
- 2000-07-24 BR BRPI0013119A patent/BRPI0013119B8/pt not_active IP Right Cessation
- 2000-07-24 IL IL14756300A patent/IL147563A0/xx unknown
- 2000-07-24 CA CA002380872A patent/CA2380872C/en not_active Expired - Lifetime
- 2000-07-24 PL PL353874A patent/PL203818B1/pl unknown
- 2000-07-24 JP JP2001516908A patent/JP3884651B2/ja not_active Expired - Lifetime
- 2000-07-24 SK SK139-2002A patent/SK288086B6/sk not_active IP Right Cessation
- 2000-07-24 AP APAP/P/2002/002418A patent/AP2002002418A0/en unknown
- 2000-07-24 PT PT00944154T patent/PT1200606E/pt unknown
- 2000-07-24 DE DE60031126T patent/DE60031126T2/de not_active Expired - Lifetime
- 2000-07-24 CN CNB008117470A patent/CN1186446C/zh not_active Expired - Lifetime
- 2000-07-24 AT AT00944154T patent/ATE341632T1/de active
- 2000-08-04 CO CO00058605A patent/CO5290295A1/es not_active Application Discontinuation
- 2000-08-10 UY UY26286A patent/UY26286A1/es not_active Application Discontinuation
- 2000-08-10 US US09/637,040 patent/US6632673B1/en not_active Expired - Lifetime
- 2000-08-10 PA PA20008499501A patent/PA8499501A1/es unknown
- 2000-08-10 GT GT200000136A patent/GT200000136A/es unknown
- 2000-08-10 AR ARP000104131A patent/AR022646A1/es active IP Right Grant
- 2000-08-10 PE PE2000000812A patent/PE20010690A1/es not_active Application Discontinuation
- 2000-08-11 TN TNTNSN00171A patent/TNSN00171A1/fr unknown
-
2002
- 2002-01-10 IL IL147563A patent/IL147563A/en active IP Right Grant
- 2002-01-25 IS IS6250A patent/IS6250A/is unknown
- 2002-02-07 MA MA26513A patent/MA26813A1/fr unknown
- 2002-02-07 ZA ZA200201072A patent/ZA200201072B/en unknown
- 2002-02-11 NO NO20020664A patent/NO20020664L/no not_active Application Discontinuation
- 2002-02-12 HR HR20020130A patent/HRP20020130A2/hr not_active Application Discontinuation
- 2002-03-05 BG BG106479A patent/BG65902B1/bg unknown
- 2002-11-19 HK HK02108367.6A patent/HK1046710B/zh unknown
-
2003
- 2003-06-11 US US10/412,444 patent/US20040009560A1/en not_active Abandoned
- 2003-06-11 US US10/412,450 patent/US7858340B2/en not_active Expired - Fee Related
-
2006
- 2006-11-13 CY CY20061101647T patent/CY1105778T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20032735L (no) | Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse | |
| DK0965578T3 (da) | Hidtil ukendt triglycerik og præparat, som omfatter dette | |
| NO20032733L (no) | Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse | |
| NO993003D0 (no) | Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter | |
| NO20012058D0 (no) | 2-ureido-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler | |
| NO20032187L (no) | Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene | |
| NO991815L (no) | Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter | |
| DK1226188T3 (da) | Fremgangsmåde til fremstilling af mannichaddukter, som indeholder polyisobutenphenol | |
| NO20020684L (no) | 3(5)-aminopyrazolderivater, fremgangsmåtet for deres fremstilling og deres anvendelse som antitumormidler | |
| TR200100366T2 (tr) | Aktif madde dağıtmaya mahsus bileşikler ve bileşimler. | |
| NO20020687L (no) | 3(5)-ureido-pyrazolderivater, fremgangsmåte for fremstilling av disse og deres anvendelse som antitumormidler | |
| NO20005146D0 (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
| DK1119557T3 (da) | Indeno-, naphto- og benzocyclohepta-dihydrothiazolderivater, fremstilling deraf og anvendelse deraf som anorektiske medikamenter | |
| DK0983995T3 (da) | Dimethyl-(3-aryl-but-3-enyl)-aminforbindelser som farmaceutiske, aktive stoffer | |
| NO992102D0 (no) | Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen | |
| DK0879058T3 (da) | Blandinger hidrørende fra frø af Eugénia Jambolana Lamarck, fremstilling af disse blandinger og visse af deres bestanddele samt anvendelse af disse som lægemidler | |
| NO20022834L (no) | Zeolitt SSZ-50, fremgangsmåte for fremstilling og anvendelse av denne | |
| NO993533L (no) | FremgangsmÕte for stabilisering av peptider, samt frysetörkede medisinske preparater som inneholder peptider erholdt ved Õ anvende fremgangsmÕten | |
| NO20016247L (no) | Streptograminderivater, deres fremstilling samt preparater inneholdende derivatene | |
| NO20022801D0 (no) | Substituerte norbornylaminoderivater, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikumsåvel som medikamenter inneholdende disse | |
| DK1118610T3 (da) | Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne | |
| NO20010219L (no) | Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel | |
| NO974934D0 (no) | 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmåte for deres fremstilling og legemidler som inneholder disse forbindelsene | |
| AR022646A1 (es) | MOLÉCULA POLINUCLEOTíDICA QUE COMPRENDE UNA SECUENCIA DE STREPTOMYCES AVERMITILES QUE DIRIGE LA RELACIoN DE AVERMICTINAS B2: B1, VECTOR RECOMBINANTE, CÉLULA HUÉSPED, PROCEDIMIENTO PARA OBTENER NUEVA CEPA DE S.AVERMITILIS, CÉLULA DE S.AVERMITILES Y COMPOSICIoN DE CICLOHEXIL B2: CICLOHEXIL B1 AVERMECT | |
| FI915492A0 (fi) | 9a-hydroxi-19,11b-oeverbryggade steroider, deras framstaellning och farmaceutiska preparat som innehaoller dem. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |